ENIGMA THERAPEUTICS
Live / Registered — Registered (as of 26 Aug 2025)
What this means for you
Registered since 26 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98556226
- Registration number
- 7911554
- Mark type
- Stylized text
- Filed
- 17 May 2024
- Published for opposition
- 10 Jun 2025
- Registered
- 26 Aug 2025
- Attorney of record
- Joe McKinney Muncy
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical compositions for the treatment of oncological diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune diseases and disorders; pharmaceutical compositions for the treatment of autoimmune diseases and disorders; biotechnological preparations for medical use for the treatment of oncological diseases and disorders; biotechnological preparations for medical use for the treatment of autoimmune diseases and disorders; biotechnological preparations for the treatment of oncological diseases and disorders; biotechnological preparations for the treatment of autoimmune diseases and disorders; antibodies for veterinary use; antibodies for medical use; pharmaceutical preparations containing antigens for the treatment of oncological diseases and disorders; pharmaceutical preparations containing antigens for the treatment of autoimmune diseases and disorders; none of the aforementioned goods for dental purposes
- Class 042 — Scientific and technological services: Pharmaceutical research and development services; pharmaceutical drug development services; research and development of new pharmaceutical products for others; biomedical research services; medicine development services; pharmaceutical research; biochemical research and analysis; scientific research in the nature of conducting clinical trials for others; structural and functional analysis of genomes; genetic testing for scientific research; research and development services in the field of immunology, biotechnology, oncology, medicine, gene therapy, immunotherapy and therapeutics; research and development services in the field of antibodies and antigens; technological services, namely, scientific research in the field of pharmaceuticals; technological services, namely, analysis in the field of pharmaceuticals; technological services, namely, testing in the field of pharmaceuticals; laboratory research services relating to the production of monoclonal antibodies; technological services, namely, scientific research relating to manufacturing methods in the field of pharmaceuticals; advisory, information and consultancy services relating to the aforementioned services; none of the aforementioned services in relation to dentistry
Owner
- Enigma Therapeutics Ltd., Hertfordshire, GB
- Enigma Therapeutics Ltd., Hertfordshire, GB
- Enigma Therapeutics Ltd., Hertfordshire, GB
Prosecution history
- 26 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 10 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Jun 2025 — PUBLISHED FOR OPPOSITION
- 04 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Dec 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Dec 2024 — NON-FINAL ACTION E-MAILED
- 16 Dec 2024 — NON-FINAL ACTION WRITTEN
- 03 Dec 2024 — ASSIGNED TO EXAMINER
- 20 Nov 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 May 2024 — NEW APPLICATION ENTERED